Remedee Labs
Remedee is the next generation pain relief offering a new and individualized therapy to every patient.
Remedee Labs has raised €23M across 2 funding rounds from 6 investors, most recently a Series A round in Dec 2022. Based in Grenoble, France; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€23M
€23,220,296
Funding rounds
2
Investors
6
distinct backers
Active since
2019-10
latest 2022-12
Funding by year
EUR raised per yearRemedee Labs — funding by year — interactive chart.
Data table
| Remedee Labs — funding by year | |
|---|---|
| 2019 | €11M |
| 2022 | €12M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-06 | Series A | €12M | BPI,Generali France,Habert Dassault Finance,HCVC,Private Investors | View deal → |
| 2019-10-01 | Series A | €11M | Hardware Club | View deal → |
Investors
6Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData